Opko Historical Income Statement

OPK Stock

USD 1.58 0.03 1.94%

Historical analysis of Opko Health income statement accounts such as Gross Profit of 334 M can show how well Opko Health performed in making a profits. Evaluating Opko Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Opko Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Opko Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Opko Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

About Opko Income Statement Analysis

Opko Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Opko Health shareholders. The income statement also shows Opko investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Opko Health Income Statement Chart

At this time, Opko Health's Total Operating Expenses is quite stable compared to the past year. Income Tax Expense is expected to rise to about 4.7 M this year, although the value of EBITDA is projected to rise to (62.2 M).

Operating Income Ebitda Cost Of Revenue Research Development Non Recurring

Operating Income

Operating Income is the amount of profit realized from Opko Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Opko Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Opko Health income statement and represents the costs associated with goods and services Opko Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Opko Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Opko Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.At this time, Opko Health's Total Operating Expenses is quite stable compared to the past year. Income Tax Expense is expected to rise to about 4.7 M this year, although the value of EBITDA is projected to rise to (62.2 M).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	596M	534.4M	475.1M	498.9M
Cost Of Revenue	1.2B	716M	545.4M	284.8M

Total Operating Expenses Cost Of Revenue

Opko Health income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Income Before Tax	Total Other Income Expense Net	Selling And Marketing Expenses	Discontinued Operations	Net Income From Continuing Ops	Non Operating Income Net Other	Non Recurring	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.48	0.48	0.33	0.48	-0.06	-0.43	-0.03	0.44	0.36	-0.13	0.03	0.31	-0.03	-0.14	-0.4	-0.59	-0.32	-0.18	-0.22	-0.76	0.42	-0.42	-0.34	-0.38
Interest Expense	0.48		0.66	0.53	0.66	-0.13	-0.02	0.19	0.65	0.57	-0.29	0.28	0.5	0.51	-0.21	-0.41	-0.16	-0.62	-0.3	-0.2	-0.01	0.67	-0.59	-0.81	-0.51
Total Revenue	0.48	0.66		0.92	0.99	-0.15	0.0	0.22	0.93	0.91	-0.14	0.08	0.92	0.59	-0.11	-0.24	-0.12	-0.51	-0.13	0.12	-0.22	0.85	-0.91	-0.66	-0.6
Gross Profit	0.33	0.53	0.92		0.9	-0.06	0.14	0.3	0.75	0.84	-0.09	0.22	0.87	0.47	-0.01	-0.11	-0.14	-0.38	-0.08	0.16	-0.18	0.83	-0.92	-0.59	-0.5
Other Operating Expenses	0.48	0.66	0.99	0.9		-0.31	-0.13	0.07	0.92	0.95	-0.29	0.06	0.96	0.66	-0.26	-0.31	-0.15	-0.56	-0.28	0.04	-0.17	0.87	-0.94	-0.61	-0.53
Operating Income	-0.06	-0.13	-0.15	-0.06	-0.31		0.79	0.86	-0.16	-0.47	0.94	0.11	-0.43	-0.6	0.95	0.47	0.17	0.42	0.93	0.49	-0.26	-0.29	0.39	-0.2	-0.25
Ebit	-0.43	-0.02	0.0	0.14	-0.13	0.79		0.91	-0.05	-0.22	0.77	0.25	-0.16	-0.2	0.84	0.61	0.28	0.28	0.79	0.5	0.21	-0.03	0.19	-0.29	-0.32
Ebitda	-0.03	0.19	0.22	0.3	0.07	0.86	0.91		0.15	-0.08	0.8	0.29	-0.04	-0.24	0.87	0.5	0.06	0.16	0.79	0.46	-0.11	0.15	0.02	-0.48	-0.52
Cost Of Revenue	0.44	0.65	0.93	0.75	0.92	-0.16	-0.05	0.15		0.83	-0.14	-0.05	0.84	0.64	-0.15	-0.32	0.1	-0.52	-0.12	0.14	-0.16	0.73	-0.77	-0.66	-0.52
Total Operating Expenses	0.36	0.57	0.91	0.84	0.95	-0.47	-0.22	-0.08	0.83		-0.42	-0.07	0.98	0.8	-0.42	-0.31	-0.18	-0.62	-0.4	0.02	-0.01	0.82	-0.93	-0.43	-0.34
Net Income	-0.13	-0.29	-0.14	-0.09	-0.29	0.94	0.77	0.8	-0.14	-0.42		-0.1	-0.38	-0.5	0.96	0.59	0.19	0.4	1.0	0.51	-0.26	-0.36	0.43	-0.01	-0.22
Income Tax Expense	0.03	0.28	0.08	0.22	0.06	0.11	0.25	0.29	-0.05	-0.07	-0.1		0.0	-0.18	0.2	0.32	-0.2	0.06	-0.11	-0.15	-0.12	0.45	-0.18	-0.35	-0.38
Selling General Administrative	0.31	0.5	0.92	0.87	0.96	-0.43	-0.16	-0.04	0.84	0.98	-0.38	0.0		0.75	-0.35	-0.24	-0.11	-0.55	-0.36	0.08	-0.03	0.83	-0.93	-0.42	-0.37
Research Development	-0.03	0.51	0.59	0.47	0.66	-0.6	-0.2	-0.24	0.64	0.8	-0.5	-0.18	0.75		-0.53	-0.22	0.11	-0.68	-0.47	-0.03	0.39	0.55	-0.63	-0.24	0.0
Income Before Tax	-0.14	-0.21	-0.11	-0.01	-0.26	0.95	0.84	0.87	-0.15	-0.42	0.96	0.2	-0.35	-0.53		0.69	0.13	0.4	0.95	0.46	-0.28	-0.22	0.36	-0.1	-0.32
Total Other Income Expense Net	-0.4	-0.41	-0.24	-0.11	-0.31	0.47	0.61	0.5	-0.32	-0.31	0.59	0.32	-0.24	-0.22	0.69		-0.02	0.27	0.6	0.33	-0.09	-0.12	0.31	0.31	-0.07
Selling And Marketing Expenses	-0.59	-0.16	-0.12	-0.14	-0.15	0.17	0.28	0.06	0.1	-0.18	0.19	-0.2	-0.11	0.11	0.13	-0.02		0.15	0.24	0.35	0.43	-0.31	0.25	-0.06	0.28
Discontinued Operations	-0.32	-0.62	-0.51	-0.38	-0.56	0.42	0.28	0.16	-0.52	-0.62	0.4	0.06	-0.55	-0.68	0.4	0.27	0.15		0.39	0.23	-0.02	-0.43	0.48	0.26	0.18
Net Income From Continuing Ops	-0.18	-0.3	-0.13	-0.08	-0.28	0.93	0.79	0.79	-0.12	-0.4	1.0	-0.11	-0.36	-0.47	0.95	0.6	0.24	0.39		0.54	-0.23	-0.36	0.42	-0.01	-0.2
Non Operating Income Net Other	-0.22	-0.2	0.12	0.16	0.04	0.49	0.5	0.46	0.14	0.02	0.51	-0.15	0.08	-0.03	0.46	0.33	0.35	0.23	0.54		0.08	0.06	-0.02	-0.2	0.09
Non Recurring	-0.76	-0.01	-0.22	-0.18	-0.17	-0.26	0.21	-0.11	-0.16	-0.01	-0.26	-0.12	-0.03	0.39	-0.28	-0.09	0.43	-0.02	-0.23	0.08		-0.11	0.12	0.0	0.3
Tax Provision	0.42	0.67	0.85	0.83	0.87	-0.29	-0.03	0.15	0.73	0.82	-0.36	0.45	0.83	0.55	-0.22	-0.12	-0.31	-0.43	-0.36	0.06	-0.11		-0.9	-0.67	-0.54
Interest Income	-0.42	-0.59	-0.91	-0.92	-0.94	0.39	0.19	0.02	-0.77	-0.93	0.43	-0.18	-0.93	-0.63	0.36	0.31	0.25	0.48	0.42	-0.02	0.12	-0.9		0.55	0.37
Net Interest Income	-0.34	-0.81	-0.66	-0.59	-0.61	-0.2	-0.29	-0.48	-0.66	-0.43	-0.01	-0.35	-0.42	-0.24	-0.1	0.31	-0.06	0.26	-0.01	-0.2	0.0	-0.67	0.55		0.62
Reconciled Depreciation	-0.38	-0.51	-0.6	-0.5	-0.53	-0.25	-0.32	-0.52	-0.52	-0.34	-0.22	-0.38	-0.37	0.0	-0.32	-0.07	0.28	0.18	-0.2	0.09	0.3	-0.54	0.37	0.62

Click cells to compare fundamentals

Opko Health Account Relationship Matchups

Opko Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	171.9K	85.4M	78.7M	108.7M	105.3M	110.6M
Interest Expense	21.5M	21.9M	18.9M	12.1M	13.5M	14.2M
Total Revenue	901.9M	1.4B	1.8B	1.0B	863.5M	906.7M
Gross Profit	329.4M	541M	581.5M	288.2M	318.1M	334.0M
Other Operating Expenses	1.1B	1.4B	1.8B	1.3B	1.0B	1.1B
Operating Income	(196.6M)	57.7M	(47.7M)	(246.2M)	(157.0M)	(149.2M)
Ebit	(54.5M)	53.7M	4.9M	(379.5M)	(170.8M)	(162.3M)
Ebitda	(54.3M)	139.1M	83.6M	(270.8M)	(65.5M)	(62.2M)
Cost Of Revenue	572.5M	894.4M	1.2B	716M	545.4M	284.8M
Total Operating Expenses	526M	487.3M	596M	534.4M	475.1M	498.9M
Net Income	(312M)	30.6M	(29.5M)	(328M)	(188.9M)	(179.4M)
Income Tax Expense	7.1M	17.6M	15.5M	(63.5M)	4.4M	4.7M
Selling General Administrative	343.3M	355.6M	468.9M	372.7M	301.7M	316.8M
Research Development	117.9M	75.3M	76.8M	73.9M	89.6M	50.0M
Income Before Tax	(304.9M)	48.7M	(14M)	(391.5M)	(184.3M)	(175.1M)
Total Other Income Expense Net	(108.3M)	(9.0M)	(33.4M)	(165.3M)	(27.3M)	(28.7M)
Net Income From Continuing Ops	(312.0M)	31.1M	(30.1M)	(328.4M)	(207.6M)	(197.2M)
Non Operating Income Net Other	(8.7M)	(9.4M)	12.9M	(14.5M)	(16.7M)	(15.9M)
Net Income Applicable To Common Shares	(314.9M)	30.6M	(30.1M)	(328.4M)	(295.6M)	(280.8M)
Tax Provision	7.1M	17.6M	15.5M	(63.5M)	(6.5M)	(6.8M)
Interest Income	1.7M	152K	28K	2.0M	4.2M	5.1M
Net Interest Income	(19.8M)	(21.8M)	(18.9M)	(10.1M)	(9.1M)	(9.6M)
Reconciled Depreciation	93.8M	85.4M	50.3M	108.7M	105.8M	73.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:

How To Invest In Opko

Details

Is Opko Stock a good investment?

Details

What is Opko Health's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.191

Earnings Share

(0.19)

Revenue Per Share

0.998

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.09)

The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Opko Historical Income Statement

About Opko Income Statement Analysis

Opko Health Income Statement Chart

Operating Income

Cost Of Revenue

Opko Health income statement Correlations

Opko Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Opko Health income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income From Continuing Ops	+ 1.0	Net Income
Other Operating Expenses	+ 0.99	Total Revenue
Selling General Administrative	+ 0.98	Total Operating Expenses
Selling General Administrative	+ 0.96	Other Operating Expenses
Income Before Tax	+ 0.96	Net Income
Total Operating Expenses	+ 0.95	Other Operating Expenses

Interest Income	- 0.94	Other Operating Expenses
Interest Income	- 0.93	Selling General Administrative
Interest Income	- 0.93	Total Operating Expenses
Interest Income	- 0.92	Gross Profit
Interest Income	- 0.91	Total Revenue
Interest Income	- 0.9	Tax Provision